1	Sequential	sequential	_	_	_	_	_	_	_
2	development	development	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	structural	structural	_	_	_	_	_	_	_
5	and	and	_	_	_	_	_	_	_
6	functional	functional	_	_	_	_	_	_	_
7	alterations	alteration	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	T	t	_	_	_	_	_	_	_
10	cells	cell	_	_	_	_	_	_	_
11	from	from	_	_	_	_	_	_	_
12	tumor-bearing	tumor-bearing	_	_	_	_	_	_	_
13	mice	mouse	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	TCR	TCR	_	_	_	_	_	_	_
3	alpha	alpha	_	_	_	_	_	_	_
4	beta	beta	_	_	_	_	_	_	_
5	or	or	_	_	_	_	_	_	_
6	-gamma	-gamma	_	_	_	_	_	_	_
7	delta	delta	_	_	_	_	_	_	_
8	chains	chain	_	_	_	_	_	_	_
9	bind	bind	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	peptide	peptide	_	_	_	_	_	_	_
12	ligand	ligand	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	whereas	whereas	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	associated	associate	_	_	_	_	_	_	_
17	CD3	cd3	_	_	_	_	_	_	_
18	deltaepsilongamma	deltaepsilongamma	_	_	_	_	_	_	_
19	and	and	_	_	_	_	_	_	_
20	TCR	TCR	_	_	_	_	_	_	_
21	zeta	zeta	_	_	_	_	_	_	_
22	subunits	subunit	_	_	_	_	_	_	_
23	couple	couple	_	_	_	_	_	_	_
24	the	the	_	_	_	_	_	_	_
25	TCR	TCR	_	_	_	_	_	_	_
26	to	to	_	_	_	_	_	_	_
27	intracellular	intracellular	_	_	_	_	_	_	_
28	signal	signal	_	_	_	_	_	_	_
29	transduction	transduction	_	_	_	_	_	_	_
30	components	component	_	_	_	_	_	_	_
31	.	.	_	_	_	_	_	_	_

1	Recently	recently	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	several	several	_	_	_	_	_	_	_
4	groups	group	_	_	_	_	_	_	_
5	have	have	_	_	_	_	_	_	_
6	described	describe	_	_	_	_	_	_	_
7	marked	marked	_	_	_	_	_	_	_
8	alterations	alteration	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	signal	signal	_	_	_	_	_	_	_
11	transduction	transduction	_	_	_	_	_	_	_
12	elements	element	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	T	t	_	_	_	_	_	_	_
15	cells	cell	_	_	_	_	_	_	_
16	from	from	_	_	_	_	_	_	_
17	cancer	cancer	_	_	_	_	_	_	_
18	patients	patient	_	_	_	_	_	_	_
19	or	or	_	_	_	_	_	_	_
20	in	in	_	_	_	_	_	_	_
21	mice	mouse	_	_	_	_	_	_	_
22	bearing	bear	_	_	_	_	_	_	_
23	tumor	tumor	_	_	_	_	_	_	_
24	for	for	_	_	_	_	_	_	_
25	a	a	_	_	_	_	_	_	_
26	few	few	_	_	_	_	_	_	_
27	weeks	week	_	_	_	_	_	_	_
28	(	(	_	_	_	_	_	_	_
29	>26	>26	_	_	_	_	_	_	_
30	days	day	_	_	_	_	_	_	_
31	)	)	_	_	_	_	_	_	_
32	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	sequence	sequence	_	_	_	_	_	_	_
3	in	in	_	_	_	_	_	_	_
4	which	which	_	_	_	_	_	_	_
5	these	these	_	_	_	_	_	_	_
6	alterations	alteration	_	_	_	_	_	_	_
7	develop	develop	_	_	_	_	_	_	_
8	is	be	_	_	_	_	_	_	_
9	unknown	unknown	_	_	_	_	_	_	_
10	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	aim	aim	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	this	this	_	_	_	_	_	_	_
5	study	study	_	_	_	_	_	_	_
6	was	be	_	_	_	_	_	_	_
7	to	to	_	_	_	_	_	_	_
8	explore	explore	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	kinetics	kinetic	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	development	development	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	alterations	alteration	_	_	_	_	_	_	_
16	in	in	_	_	_	_	_	_	_
17	signal	signal	_	_	_	_	_	_	_
18	transduction	transduction	_	_	_	_	_	_	_
19	molecules	molecule	_	_	_	_	_	_	_
20	(	(	_	_	_	_	_	_	_
21	TCR	TCR	_	_	_	_	_	_	_
22	zeta	zeta	_	_	_	_	_	_	_
23	chain	chain	_	_	_	_	_	_	_
24	,	,	_	_	_	_	_	_	_
25	NF	NF	_	_	_	_	_	_	_
26	kappaB	kappaB	_	_	_	_	_	_	_
27	family	family	_	_	_	_	_	_	_
28	proteins	protein	_	_	_	_	_	_	_
29	,	,	_	_	_	_	_	_	_
30	and	and	_	_	_	_	_	_	_
31	tyrosine	tyrosine	_	_	_	_	_	_	_
32	kinase	kinase	_	_	_	_	_	_	_
33	p56(lck))	p56(lck))	_	_	_	_	_	_	_
34	in	in	_	_	_	_	_	_	_
35	mice	mouse	_	_	_	_	_	_	_
36	bearing	bear	_	_	_	_	_	_	_
37	MC38	mc38	_	_	_	_	_	_	_
38	colon	colon	_	_	_	_	_	_	_
39	adenocarcinoma	adenocarcinoma	_	_	_	_	_	_	_
40	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	results	result	_	_	_	_	_	_	_
3	demonstrate	demonstrate	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	alterations	alteration	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	NF	NF	_	_	_	_	_	_	_
8	kappaB	kappab	_	_	_	_	_	_	_
9	family	family	_	_	_	_	_	_	_
10	proteins	protein	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	specifically	specifically	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	failure	failure	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	p65	p65	_	_	_	_	_	_	_
17	translocation	translocation	_	_	_	_	_	_	_
18	to	to	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	nucleus	nucleus	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	occur	occur	_	_	_	_	_	_	_
23	earlier	earlier	_	_	_	_	_	_	_
24	and	and	_	_	_	_	_	_	_
25	more	more	_	_	_	_	_	_	_
26	frequently	frequently	_	_	_	_	_	_	_
27	than	than	_	_	_	_	_	_	_
28	the	the	_	_	_	_	_	_	_
29	decrease	decrease	_	_	_	_	_	_	_
30	in	in	_	_	_	_	_	_	_
31	zeta-chain	zeta-chain	_	_	_	_	_	_	_
32	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	defects	defect	_	_	_	_	_	_	_
3	are	be	_	_	_	_	_	_	_
4	paralleled	parallel	_	_	_	_	_	_	_
5	by	by	_	_	_	_	_	_	_
6	an	an	_	_	_	_	_	_	_
7	impaired	impaired	_	_	_	_	_	_	_
8	ability	ability	_	_	_	_	_	_	_
9	to	to	_	_	_	_	_	_	_
10	produce	produce	_	_	_	_	_	_	_
11	Th1	th1	_	_	_	_	_	_	_
12	cytokines	cytokine	_	_	_	_	_	_	_
13	(	(	_	_	_	_	_	_	_
14	IL-2	IL-2	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	IFN-gamma	IFN-gamma	_	_	_	_	_	_	_
17	)	)	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	initial	initial	_	_	_	_	_	_	_
3	changes	change	_	_	_	_	_	_	_
4	are	be	_	_	_	_	_	_	_
5	followed	follow	_	_	_	_	_	_	_
6	by	by	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	eventual	eventual	_	_	_	_	_	_	_
9	loss	loss	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	TCR	TCR	_	_	_	_	_	_	_
12	zeta	zeta	_	_	_	_	_	_	_
13	chain	chain	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	p56(lck)	p56(lck)	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	a	a	_	_	_	_	_	_	_
18	marked	marked	_	_	_	_	_	_	_
19	decrease	decrease	_	_	_	_	_	_	_
20	in	in	_	_	_	_	_	_	_
21	cytotoxic	cytotoxic	_	_	_	_	_	_	_
22	function	function	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	An	an	_	_	_	_	_	_	_
2	increased	increase	_	_	_	_	_	_	_
3	rate	rate	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	lysosomal	lysosomal	_	_	_	_	_	_	_
6	degradation	degradation	_	_	_	_	_	_	_
7	is	be	_	_	_	_	_	_	_
8	one	one	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	mechanisms	mechanism	_	_	_	_	_	_	_
12	responsible	responsible	_	_	_	_	_	_	_
13	for	for	_	_	_	_	_	_	_
14	the	the	_	_	_	_	_	_	_
15	loss	loss	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	zeta-chain	zeta-chain	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

